Divi's Laboratories Ltd.

BSE: DIVISLAB532488ISIN INE361B01024

Healthcare
Pharmaceuticals
BSE 100

BSE listing

Share price

₹9,367.00+20.50 (+0.22%)

as of 18 Sep 2026

52W high: ₹10,000.00
52W low: ₹5,637.50
Off 52W high: -6.33%
1M return: +9.88%
3M return: +38.95%
6M return: +53.50%
1Y return: +53.50%
20D avg volume: 30,277
50 DMA: ₹8,386.48
200 DMA: ₹6,898.96

Key ratios Consolidated

Market cap: ₹2,48,664 Cr
Current price: ₹9,367.00
52W high / low: ₹10,000.00 / ₹5,637.50
Face value: ₹2.00
P/E: 85.01
P/B: —
EPS (TTM): ₹110.18
Book value / share: —
ROE: —
ROCE: 19.00%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-128.00 Cr
Interest cover: 148.30
Dividend yield: 0.32%
Dividend / share (TTM): ₹30.00
Payout: 27.23%
Cash conversion cycle: 197.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	3,080	2,831	2,604	2,715	2,410	2,585	2,319	2,338	2,118	2,303	1,855	1,909
	64.00	155.00	88.00	145.00	119.00	86.00	82.00	106.00	79.00	79.00	95.00	86.00
	1,964	2,023	1,838	1,948	1,796	1,807	1,675	1,722	1,593	1,669	1,461	1,526
	1,503	1,214	1,217	937.00	1,010	931.00	1,021	976.00	893.00	898.00	794.00	711.00
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	6.00	—	—
	408.00	381.00	367.00	354.00	340.00	350.00	297.00	304.00	292.00	297.00	268.00	266.00
	6.00	6.00	6.00	8.00	3.00	1.00	—	1.00	—	2.00	—	1.00
	133.00	120.00	118.00	113.00	112.00	107.00	99.00	99.00	97.00	95.00	95.00	95.00
	431.00	397.00	402.00	400.00	385.00	368.00	357.00	349.00	351.00	373.00	369.00	354.00
	1,180	963.00	854.00	912.00	733.00	864.00	726.00	722.00	604.00	713.00	489.00	469.00
	0.00	0.00	-74.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	1,180	963.00	780.00	912.00	733.00	864.00	726.00	722.00	604.00	713.00	489.00	469.00
	278.00	212.00	197.00	223.00	188.00	202.00	137.00	212.00	174.00	175.00	131.00	121.00
	902.00	751.00	583.00	689.00	545.00	662.00	589.00	510.00	430.00	538.00	358.00	348.00
	33.95	28.31	21.98	25.97	20.49	24.93	22.20	19.20	16.20	20.25	13.50	13.11
Key metrics
	1,319	1,089	904.00	1,033	848.00	972.00	825.00	822.00	701.00	810.00	584.00	565.00
	42.80%	38.50%	34.70%	38.00%	35.20%	37.60%	35.60%	35.20%	33.10%	35.20%	31.50%	29.60%
	29.30%	26.50%	22.40%	25.40%	22.60%	25.60%	25.40%	21.80%	20.30%	23.40%	19.30%	18.20%
	—	5.40%	—	5.60%	—	5.60%	—	—	—	—	—	—
	27.80%	9.50%	12.30%	16.10%	13.80%	12.20%	25.00%	22.50%	—	—	—	—
	65.50%	13.40%	-1.00%	35.10%	26.70%	23.00%	64.50%	46.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	11,230	10,560	9,360	7,845	7,768	8,960	6,969	5,394	4,946	3,913
	452.00	507.00	352.00	339.00	344.66	113.87	62.56	189.63	155.63	113.44
	7,773	7,605	6,796	6,021	5,744	5,390	4,366	3,765	3,247	2,795
	4,871	4,378	3,821	3,232	3,008	3,477	2,397	2,198	2,104	1,529
	0.00	0.00	0.00	6.00	22.33	14.41	5.31	16.11	25.92	2.16
	1,510	1,442	1,243	1,094	975.02	946.16	825.76	621.05	542.27	456.06
	26.00	23.00	2.00	3.00	0.67	0.80	0.87	6.10	3.50	1.33
	484.00	463.00	402.00	378.00	343.18	311.51	255.59	186.24	168.90	—
	1,630	1,584	1,424	1,417	1,371	1,165	959.62	842.66	706.93	660.95
	3,909	3,462	2,916	2,163	2,369	3,684	2,666	1,819	1,855	1,231
	-74.00	-74.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	3,835	3,388	2,916	2,163	2,369	3,684	2,666	1,819	1,855	1,231
	910.00	820.00	725.00	563.00	545.25	723.05	681.75	442.92	502.33	354.32
	2,925	2,568	2,191	1,600	1,823	2,960	1,984	1,377	1,353	877.01
	110.21	96.75	82.53	60.27	68.69	111.52	74.75	51.85	50.96	—
Key metrics
	4,345	3,874	3,320	2,544	2,712	3,996	2,922	2,012	2,027	1,233
	38.69%	36.70%	35.50%	32.40%	34.90%	44.60%	41.90%	37.30%	41.00%	31.50%
	26.05%	24.30%	23.40%	20.40%	23.50%	33.00%	28.50%	25.50%	27.30%	22.40%
	—	19.00%	18.90%	—	—	—	—	—	—	—
	—	12.80%	19.30%	1.00%	-13.30%	28.60%	29.20%	9.10%	26.40%	—
	—	17.20%	36.90%	-12.30%	-38.40%	49.20%	44.20%	1.80%	54.20%	—
	—	218.00	215.00	—	—	—	—	—	—	—
	—	1.07	0.75	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	-128.00	-413.00	—	—	—	—	—	—	—
	—	197.9	197.2	—	—	—	—	—	—	—
Balance sheet
	—	20,033	16,932	—	—	—	—	—	—	—
	—	11,096	10,081	—	—	—	—	—	—	—
	—	128.00	415.00	—	—	—	—	—	—	—
	—	2,984	2,731	—	—	—	—	—	—	—
	—	3,954	3,236	—	—	—	—	—	—	—
	—	736.00	383.00	—	—	—	—	—	—	—
	—	6,515	5,437	—	—	—	—	—	—	—
	—	1,211	910.00	—	—	—	—	—	—	—
	—	2,043	1,452	—	—	—	—	—	—	—
	—	0.00	2.00	—	—	—	—	—	—	—
	—	0.00	2.00	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	16,761	14,969	—	—	—	—	—	—	—
Cash flow
	—	2,738	1,653	—	—	—	—	—	—	—
	—	-2,219	-804.00	—	—	—	—	—	—	—
	—	-804.00	-799.00	—	—	—	—	—	—	—
	—	2,520	1,438	—	—	—	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	2,974	2,793	2,578	2,660	2,357	2,536	2,297	2,302	2,063	2,259	1,808	1,868
	63.00	154.00	87.00	146.00	119.00	87.00	82.00	105.00	79.00	79.00	94.00	85.00
	1,872	1,976	1,793	1,886	1,729	1,762	1,649	1,672	1,539	1,638	1,412	1,489
	1,495	1,173	1,191	907.00	989.00	910.00	1,015	953.00	882.00	910.00	771.00	706.00
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	397.00	370.00	356.00	344.00	330.00	341.00	288.00	296.00	285.00	290.00	261.00	260.00
	6.00	6.00	6.00	8.00	3.00	0.00	—	1.00	—	2.00	—	1.00
	132.00	120.00	116.00	113.00	112.00	107.00	99.00	98.00	97.00	94.00	95.00	94.00
	409.00	377.00	370.00	370.00	367.00	345.00	334.00	323.00	331.00	352.00	348.00	334.00
	1,165	971.00	872.00	920.00	747.00	861.00	730.00	735.00	603.00	700.00	490.00	464.00
	0.00	0.00	-74.00	0.00	0.00	0.00	—	—	—	—	—	—
	1,165	971.00	798.00	920.00	747.00	861.00	730.00	735.00	603.00	700.00	490.00	464.00
	274.00	215.00	200.00	224.00	190.00	194.00	136.00	217.00	173.00	169.00	132.00	122.00
	891.00	756.00	598.00	696.00	557.00	667.00	594.00	518.00	430.00	531.00	358.00	342.00
	33.55	28.44	22.56	26.24	20.95	25.12	22.39	19.51	16.18	19.99	13.50	12.89
Key metrics
	1,303	1,097	920.00	1,041	862.00	968.00	829.00	834.00	700.00	796.00	585.00	559.00
	43.80%	39.30%	35.70%	39.10%	36.60%	38.20%	36.10%	36.20%	33.90%	35.20%	32.40%	29.90%
	30.00%	27.10%	23.20%	26.20%	23.60%	26.30%	25.90%	22.50%	20.80%	23.50%	19.80%	18.30%
	—	5.40%	—	5.70%	—	5.60%	—	—	—	—	—	—
	26.20%	10.10%	12.20%	15.60%	14.30%	12.30%	27.00%	23.20%	—	—	—	—
	60.00%	13.30%	0.70%	34.40%	29.50%	25.60%	65.90%	51.50%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	11,005	10,388	9,198	7,665	7,625	8,880	6,799	5,311	4,880	3,837
	450.00	506.00	352.00	337.00	349.01	111.26	62.53	189.86	156.58	112.48
	7,527	7,384	6,621	5,870	5,620	5,315	4,233	3,687	3,203	2,730
	4,766	4,260	3,760	3,210	2,979	3,440	2,366	2,183	2,082	1,524
	0.00	0.00	0.00	—	—	—	—	—	—	—
	1,467	1,400	1,210	1,067	953.05	926.55	808.68	608.36	530.72	446.27
	26.00	23.00	1.00	3.00	0.52	0.65	0.69	6.06	3.50	1.33
	481.00	461.00	401.00	376.00	342.07	310.55	254.65	185.95	168.81	142.42
	1,526	1,484	1,332	1,341	1,295	1,087	903.75	798.21	662.15	635.43
	3,928	3,510	2,929	2,132	2,354	3,677	2,628	1,813	1,833	1,219
	-74.00	-74.00	0.00	—	—	—	—	—	—	—
	3,854	3,436	2,929	2,132	2,354	3,677	2,628	1,813	1,833	1,219
	913.00	829.00	720.00	556.00	545.95	727.98	673.15	440.58	500.58	349.78
	2,941	2,607	2,209	1,576	1,808	2,949	1,955	1,373	1,333	869.58
	110.79	98.19	83.20	59.37	68.11	111.07	73.63	51.71	50.20	32.76
Key metrics
	4,361	3,920	3,331	2,511	2,697	3,988	2,883	2,005	2,006	1,363
	39.63%	37.70%	36.20%	32.80%	35.40%	44.90%	42.40%	37.80%	41.10%	35.50%
	26.72%	25.10%	24.00%	20.60%	23.70%	33.20%	28.80%	25.80%	27.30%	22.70%
	—	19.30%	19.00%	—	—	—	—	—	—	—
	—	12.90%	20.00%	0.50%	-14.10%	30.60%	28.00%	8.80%	27.20%	—
	—	18.00%	40.20%	-12.80%	-38.70%	50.80%	42.40%	3.00%	53.30%	—
	—	192.00	213.00	—	—	—	—	—	—	—
	—	1.04	0.75	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	-85.00	-394.00	—	—	—	—	—	—	—
	—	202.0	198.8	—	—	—	—	—	—	—
Balance sheet
	—	19,954	16,824	—	—	—	—	—	—	—
	—	11,034	9,979	—	—	—	—	—	—	—
	—	85.00	396.00	—	—	—	—	—	—	—
	—	3,228	2,855	—	—	—	—	—	—	—
	—	3,711	3,033	—	—	—	—	—	—	—
	—	716.00	379.00	—	—	—	—	—	—	—
	—	6,514	5,436	—	—	—	—	—	—	—
	—	1,190	880.00	—	—	—	—	—	—	—
	—	2,019	1,420	—	—	—	—	—	—	—
	—	0.00	2.00	—	—	—	—	—	—	—
	—	0.00	2.00	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	16,711	14,895	—	—	—	—	—	—	—
Cash flow
	—	2,711	1,650	—	—	—	—	—	—	—
	—	-2,218	-803.00	—	—	—	—	—	—	—
	—	-802.00	-797.00	—	—	—	—	—	—	—
	—	2,519	1,437	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +10.86%
Sales CAGR 5Y: +8.85%
Sales CAGR 10Y: —
Profit CAGR 3Y: +12.97%
Profit CAGR 5Y: +5.93%
Profit CAGR 10Y: —
Sales YoY (TTM): +15.94%
Profit YoY (TTM): +25.90%

Consolidated

Sales CAGR 3Y: +10.78%
Sales CAGR 5Y: +8.67%
Sales CAGR 10Y: —
Profit CAGR 3Y: +12.09%
Profit CAGR 5Y: +5.29%
Profit CAGR 10Y: —
Sales YoY (TTM): +16.35%
Profit YoY (TTM): +26.84%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 51.87%

Holder	Type	Holding	Previous	Change
NILIMA PRASAD DIVI	Promoter Group	20.34%	—	—
SATCHANDRA KIRAN DIVI	Promoter Group	20.34%	—	—
SWARNA LATHA DIVI	Promoter Group	5.27%	—	—
SBI MUTUAL FUND	Public	3.90%	—	—
GOVERNMENT OF SINGAPORE	Public	3.64%	—	—
DIVI'S BIOTECH PRIVATE LIMITED	Promoter Group	3.01%	—	—
MURALI KRISHNA PRASAD DIVI	Promoter	2.85%	—	—
Life Insurance Corporation of India	Public	2.53%	—	—
HDFC MUTUAL FUND	Public	2.07%	—	—
AXIS MUTUAL FUND TRUSTEE LIMITED	Public	1.38%	—	—
NIPPON LIFE INDIA TRUSTEE LTD	Public	1.29%	—	—
GOVERNMENT PENSION FUND GLOBAL	Public	1.23%	—	—
MADHUSUDANA RAO DIVI	Promoter Group	0.06%	—	—
RADHAKRISHNA RAO DIVI	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Newspaper Clippings - Special Window for transfer and dematerialisation of physical shares12 Sep 2026 · Company Update / Newspaper Publication
Submission of Scrutinizer''s report on 36th AGM resolutions.10 Aug 2026 · AGM/EGM / AGM
Outcome of 36th AGM - submission of AGM proceedings, voting results and Scrutinizer''s report.10 Aug 2026 · AGM/EGM / AGM
Submission of transcript of Earnings Conference Call held on August 01, 20266 Aug 2026 · Company Update / Earnings Call Transcript
Newspaper clippings regarding unaudited financial results of the Company for the quarter ended June 30, 20263 Aug 2026 · Company Update / Newspaper Publication
Intimation of Q1FY27 earnings call audio recording.1 Aug 2026 · Company Update / Analyst / Investor Meet
As per enclosed letter.1 Aug 2026 · Company Update / Change in Management
Outcome of Board meeting held on August 01, 2026.1 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation of retirement of Senior Management Personnel as detailed in the enclosed letter.31 Jul 2026 · Company Update / Change in Management
Schedule of earnings conference call for Q1 FY2724 Jul 2026 · Company Update / Analyst / Investor Meet
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve the unaudited financial ....20 Jul 2026 · Board Meeting / Board Meeting
Newspaper Clippings - Notice of 36th AGM, e-voting & other information17 Jul 2026 · Company Update / Newspaper Publication
Intimation of notice of 36th AGM to be held on August 10, 2026.15 Jul 2026 · AGM/EGM / AGM
Submission of BRSR report for the FY 2025-26.15 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of 36th Annual General Meeting and Annual Report for the financial year 2025-26.15 Jul 2026 · Others / Reg. 34 (1) Annual Report
Notice regarding 36th Annual General Meeting, Record Date for dividend and other information13 Jul 2026 · Company Update / Newspaper Publication
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 20267 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of Trading Window from July 01, 2026.30 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
As per enclosed letter.11 Jun 2026 · Company Update / General
Copies of Newspaper Publication - Notice to the shareholders regarding transfer of unclaimed dividends and equity shares to IEPF4 Jun 2026 · Company Update / Newspaper Publication
Submission of transcript of Earnings Conference Call held on May 23, 202629 May 2026 · Company Update / Earnings Call Transcript
Newspaper publications regarding audited financial results of the Company for the quarter and year ended March 31, 202625 May 2026 · Company Update / Newspaper Publication
As per enclosed letter.25 May 2026 · Result / Financial Results
Audio recording of Q4 FY26 earnings conference call held on May 23, 2026.23 May 2026 · Company Update / Analyst / Investor Meet
The Board of Directors at its meeting held on May 23, 2026 have recommended a dividend of Rs. 30/- per share (i.e. @1500%), subject to approval at the ensuing Annual General Meeting.23 May 2026 · Corp Action / Dividend Updates
As per enclosed intimation letter.23 May 2026 · Corp. Action / Record Date
Outcome of Board meeting held on May 23, 2026.23 May 2026 · Board Meeting / Outcome of Board Meeting
Intimation of schedule of earnings conference call for the quarter and year ended March 31, 2026 to be held on May 23, 2026 at 14:30 Hrs (IST).15 May 2026 · Company Update / Analyst / Investor Meet
Copy of Newspaper Publication regarding loss of Share Certificate.15 May 2026 · Company Update / Newspaper Publication
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve audited standalone and consolidated ....14 May 2026 · Board Meeting / Board Meeting
Certificate pursuant to Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.6 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of Trading Window from April 01, 2026 till 48 hours of declaration of audited financial results for the quarter and financial year ended March 31, 2026.31 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation about Draft Order issued under Section 144C(1) of the Income Tax Act, 1961 for FY2022-23.21 Mar 2026 · Company Update / General
Newspaper clippings - Special Window for transfer and dematerialisation of physical shares.14 Mar 2026 · Company Update / Newspaper Publication
Submission of transcript of Earnings Conference Call held on February 11, 202614 Feb 2026 · Company Update / Earnings Call Transcript
As enclosed12 Feb 2026 · Company Update / Newspaper Publication
Audio recording of Q3FY26 earnings conference call held on February 11, 2026.11 Feb 2026 · Company Update / Analyst / Investor Meet
Outcome of Board Meeting held on February 11, 2026.11 Feb 2026 · Board Meeting / Outcome of Board Meeting
Schedule of earnings conference call for Q3FY26 to be held on February 11, 2026 at 15.00 hrs (IST).3 Feb 2026 · Company Update / Analyst / Investor Meet
Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the unaudited financial ....30 Jan 2026 · Board Meeting / Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 30.0000	24 Jul 2026	24 Jul 2026	—
Final Dividend - Rs. - 30.0000	25 Jul 2025	25 Jul 2025	—
Final Dividend - Rs. - 30.0000	2 Aug 2024	2 Aug 2024	—

Board meetings

1 Aug 2026 Board Meeting - Financial Results